Kuan Jiang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 17
- Advanced biosensing and bioanalysis techniques 8
- Circular RNAs in diseases 6
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 6
- Co-authors
- Chwee Teck Lim (8 shared papers)Weiyue Lu (17 shared papers)Tongle Zhi (14 shared papers)Yingyi Wang (9 shared papers)Tianfu Yu (9 shared papers)Ren Hao Soon (1 shared paper)Ramanathan Vaidyanathan (1 shared paper)Pan Zhang (1 shared paper)
- Journals
- Advanced Science (6 papers)Journal of Controlled Release (5 papers)Acta Pharmaceutica Sinica B (3 papers)Acta Biomaterialia (3 papers)Lab on a Chip (2 papers)
- Partner nations
- ChinaSouth KoreaSingapore
In The Last Decade
Kuan Jiang
60 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 121
- Cancer Research 448
- Biomaterials 222
- Pharmaceutical Science 92
- Molecular Biology 971
- Biomedical Engineering 374
Countries citing papers authored by Kuan Jiang
This map shows the geographic impact of Kuan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuan Jiang more than expected).
Fields of papers citing papers by Kuan Jiang
This network shows the impact of papers produced by Kuan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuan Jiang. The network helps show where Kuan Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Kuan Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 206 | |
| 2 | 2017 | 112 | |
| 3 | 2017 | 108 | |
| 4 | 2018 | 84 | |
| 5 | 2020 | 67 | |
| 6 | 2016 | 54 | |
| 7 | 2021 | 52 | |
| 8 | 2018 | 49 | |
| 9 | 2022 | 48 | |
| 10 | 2021 | 48 | |
| 11 | 2017 | 45 | |
| 12 | 2019 | 44 | |
| 13 | 2013 | 41 | |
| 14 | MicroRNA-1179 inhibits glioblastoma cell proliferation and cell cycle progression via directly targeting E2F transcription factor 5. | 2017 | 41 |
| 15 | 2018 | 40 | |
| 16 | 2018 | 38 | |
| 17 | 2019 | 38 | |
| 18 | MicroRNA-1301 inhibits proliferation of human glioma cells by directly targeting N-Ras. | 2017 | 35 |
| 19 | 2023 | 34 | |
| 20 | 2018 | 31 |
About Kuan Jiang
Kuan Jiang is a scholar working on Molecular Biology, Cancer Research, Biomaterials, Biomedical Engineering and Oncology, having authored 66 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (17 papers), Nanoparticle-Based Drug Delivery (9 papers), Advanced biosensing and bioanalysis techniques (8 papers), MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Cancer Research (448 citations), Biomaterials (222 citations), Pharmaceutical Science (92 citations), Molecular Biology (971 citations) and Biomedical Engineering (374 citations). Kuan Jiang has collaborated with scholars based in China, South Korea and Singapore. Frequent co-authors include Chwee Teck Lim, Weiyue Lu, Tongle Zhi, Yingyi Wang, Tianfu Yu, Ren Hao Soon, Ramanathan Vaidyanathan, Pan Zhang, Changyou Zhan and Junxia Zhang. Their work appears in journals such as Advanced Science, Journal of Controlled Release, Acta Pharmaceutica Sinica B, Acta Biomaterialia and Lab on a Chip.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.